{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T17:41:27Z","timestamp":1725471687342},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1991,2,1]],"date-time":"1991-02-01T00:00:00Z","timestamp":665366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1991,2]]},"DOI":"10.1007\/bf00319708","type":"journal-article","created":{"date-parts":[[2004,12,10]],"date-time":"2004-12-10T05:24:18Z","timestamp":1102656258000},"page":"34-38","source":"Crossref","is-referenced-by-count":10,"title":["Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease"],"prefix":"10.1007","volume":"238","author":[{"given":"Henry C.","family":"Weinstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Teunisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem A.","family":"Gool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"103","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987","unstructured":"American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd end, revised. American Psychiatric Association, Washington, DC, pp 103?107","edition":"3rd end, revise"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ddr.430120302","volume":"12","author":"RE Becker","year":"1988","unstructured":"Becker RE, Giacobini E (1988) Mechanism of cholinesterase inhibitions in senile dementia of the Alzheimer type: clinical, pharmacological and therapeutic aspects. Drug Dev Res 12:163?195","journal-title":"Drug Dev Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.299.6712.1375","volume":"299","author":"H Brodaty","year":"1989","unstructured":"Brodaty H, Gresham M (1989) Effects of a training programme to reduce stress in carers of patients with dementia. Br Med J 299:1375?1379","journal-title":"Br Med J"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/bmj.300.6723.495","volume":"300","author":"G Chatellier","year":"1990","unstructured":"Chatellier G, Lacomblez L (1990) Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Br Med J 300:495?499","journal-title":"Br Med J"},{"key":"CR5","first-page":"379","volume-title":"Alzheimer's disease","author":"ER Gamzu","year":"1989","unstructured":"Gamzu ER, Thal LJ, Davis KL (1989) Therapeutic trials using tacrine and other cholinesterase inhibitors. In: Wurtmann RJ, Corkin S, Growdon JHA, Ritter-Walkes E (eds) Alzheimer's disease. Proceedings of the Fifth Meeting of the International Group on the Pharmacology of Memory Disorders Associated with Aging, Zurich 1989 Center for Brain Sciences and Metabolism, Cambridge, Massachusetts, pp 379?386"},{"key":"CR6","first-page":"237","volume-title":"Current research in Alzheimer therapy","author":"S Gauthier","year":"1988","unstructured":"Gauthier S, Masson H, Gauthier L, Bouchard R, Collier B, Bacher Y, Baily P, Becker R, Bergman H, Charbonneau R, Dastoor D, Gayton D, Kennedy J, Kissel C, Krieger M, Kushnir S, Lamontagne A, St-Martin M, Morin J, Nair NPV, Neirinik L, Ratner J, Suissa S, Tesfaye Y, Vida S (1988) Tetrahydroaminocridine and lecithin in Alzheimer's disease. In: Giacobini E, Becker R (eds) Current research in Alzheimer therapy, Taylor & Francis, London, pp 237?245"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1017\/S0317167100029899","volume":"16","author":"S Gauthier","year":"1989","unstructured":"Gauthier S, Bouchard R, Bacher Y, Bailey P, Bergman H, Carrier L, Charbonneau R, Clarfield M, Collier B, Dastoor D, Gauthier L, Germain M, Kissel M, Krieger M, Kushnir S, Lamontagne A, Morin J, Nair NPV, Neirinick L, Ratner J, St-Martin M, Suissa S, Tesfaye Y (1989) Progress report on the Canadian Multicenter Trial of Tetrahydroaminoacridine with lecithin in Alzheimer's disease. Can J Neurol Sci 16 [Suppl]:543?546","journal-title":"Can J Neurol Sci"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199005033221804","volume":"322","author":"S Gauthier","year":"1990","unstructured":"Gauthier S, Bouchard R, Lamontagne A, Bailey P, Bergman H, Carrier L, Charbonneau R, Clarfield M, Collier B, Dastoor D, Gauthier L, Germain M, Kissel C, Krieger M, Kushnir S, Masson H, Morin J, Nair V, Neirinick L, Suissa S (1990) Tetrahydroaminocridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. N Engl J Med 322:1272?1276","journal-title":"N Engl J Med"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189?198","journal-title":"J Psychiatr Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ageing\/18.4.223","volume":"18","author":"DR Forsyth","year":"1989","unstructured":"Forsyth DR, Surmon DJ, Morgan RA, Wilcock GK (1989) Clinical experience with side effects of Tacrine Hydrochloride in Alzheimer's disease: a pilot study. Age Ageing 18:223?229","journal-title":"Age Ageing"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","volume":"32","author":"VC Hachinski","year":"1975","unstructured":"Hachinski VC, Llif LD, Zilkha E, Du Boulay GH, McAllisteer VL, Marshall J, Ross Russell RW, Symon L (1975) Cerebral blood flow in dementia. Arch Neurol 32:632?637","journal-title":"Arch Neurol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56?62","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198706183162512","volume":"316","author":"N Herman","year":"1987","unstructured":"Herman N, Sadavoy J, Steingart A (1987) Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer's type. N Engl J Med 316:1603?1604","journal-title":"N Engl J Med"},{"key":"CR14","first-page":"1604","volume":"316","author":"M Kopelman","year":"1987","unstructured":"Kopelman M (1987) Oral tetrahydroaminocridine in long-term treatment of senile dementia, Alzheimer's type. N Engl J Med 316:1604","journal-title":"N Engl J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D (1984) Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA work group under the auspices of Department of Health and Human Service Task Force on Alzheimer's disease. Neurology 34:939?944","journal-title":"Neurology"},{"key":"CR16","first-page":"231","volume-title":"Current research in Alzheimer therapy","author":"H Nyback","year":"1988","unstructured":"Nyback H, Nyman H, Ohman G, Nordgren I, Lindstrom B (1988) Preliminary experiences and results with THA for the amelioration of symptoms of Alzheimer's disease. In: Giacobini E, Becker R (eds) Current research in Alzheimer therapy, Taylor & Francis, London, pp 231?236"},{"key":"CR17","first-page":"27","volume":"1","author":"EK Perry","year":"1985","unstructured":"Perry EK, Perry RH (1985) A review of neuropathological and neurochemical correlates of Alzheimer's disease. Dan Med Bull 32 [Suppl] 1:27?34","journal-title":"Dan Med Bull 32"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1136\/bmj.2.6150.1457","volume":"2","author":"EK Perry","year":"1978","unstructured":"Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson P, Perry R (1978) Correlation of cholinergic abnormalities with senile plaques and mental scores in senile dementia. Br Med J 2:1457?1459","journal-title":"Br Med J"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1056\/NEJM198706183162512","volume":"316","author":"FJ Pirossolo","year":"1987","unstructured":"Pirossolo FJ, Baskin DS, Swihart AA, Appel SH (1987) Oral tetrahydroaminocridine in long-term treatment of senile dementia, Alzheimer's type. N Engl J Med 316:1603","journal-title":"N Engl J Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1192\/bjp.149.6.698","volume":"149","author":"M Roth","year":"1986","unstructured":"Roth M, Tym E, Mountjoy C (1986) CAMDEX: a standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698?709","journal-title":"Br J Psychiatry"},{"key":"CR21","first-page":"1604","volume":"316","author":"GW Small","year":"1987","unstructured":"Small GW, Spar JE, Plotkin DA (1987) Oral tetrahydroaminocridine in long-term treatment of senile dementia, Alzheimer's type. N Engl J Med 316:1604","journal-title":"N Engl J Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM198611133152001","volume":"315","author":"WK Summers","year":"1986","unstructured":"Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A (1986) Oral tetrahydroaminocridine in long-term treatment of senile dementia, Alzheimer's type. N Engl J Med 315:1241?1245","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"CR23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000116478","volume":"29","author":"WK Summers","year":"1989","unstructured":"Summers WK, Tachiki KH, Kling A (1989) Tacrine in the treatment of Alzheimer's disease. Eur Neurol 29 [Suppl 3]:28?32","journal-title":"Eur Neurol"},{"key":"CR24","first-page":"1604","volume":"316","author":"PN Tariot","year":"1988","unstructured":"Tariot PN, Caine ED (1988) Oral tetrahydroaminocridine in long-term treatment of senile dementia, Alzheimer's type. N Engl J Med 316:1604?1605","journal-title":"N Engl J Med"},{"key":"CR25","doi-asserted-by":"crossref","unstructured":"Teunisse S, Derix MMA, Crevel H van (1990) Assessing the severity of dementia: patient and caregiver. Arch Neurol (in press)","DOI":"10.1001\/archneur.1991.00530150042015"},{"key":"CR26","volume-title":"Family relations examined","author":"M Vernooy-Dassen","year":"1990","unstructured":"Vernooy-Dassen M, Furer J, Persoon J (1990) The primary carer of elderly with dementia (in Dutch). In: Acker J van, Gerris J (eds) Family relations examined. Swets en Zeitlinger, Lisse (in press)"},{"key":"CR27","first-page":"717","volume":"24","author":"PFJ Verstraten","year":"1988","unstructured":"Verstraten PFJ (1988) The GIP: an observational ward behaviour scale. Psychopharmacol Bull 24:717?719","journal-title":"Psychopharmacol Bull"},{"key":"CR28","first-page":"95","volume-title":"Current research in Alzheimer therapy","author":"RJ Wurtmann","year":"1988","unstructured":"Wurtmann RJ, Blusztajn JK, Growdon JH, Ulus IH (1988) Cholinesterase inhibitors increase the brain's need for free choline. In: Giacobini E, Becker R (eds) Current research in Alzheimer therapy. Taylor & Francis, London, pp 95?99"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Petersen J (1980) Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 20:649?655","journal-title":"Gerontologist"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00319708.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00319708\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00319708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T16:27:18Z","timestamp":1586017638000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00319708"}},"subtitle":["Effect on cognition, functioning in daily life, behavioural disturbances and burden experienced by the carers"],"short-title":[],"issued":{"date-parts":[[1991,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1991,2]]}},"alternative-id":["BF00319708"],"URL":"https:\/\/doi.org\/10.1007\/bf00319708","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,2]]}}}